Adia Med’s primary focus is collaborating with healthcare providers and insurance companies to facilitate Autologous Hematopoietic Stem Cell Transplantation (AHSCT) treatments for Multiple Sclerosis (MS) patients. ADIA envisions a future where AHSCT becomes a widely accessible and transformative treatment option for individuals with MS.

In line with its mission, ADIA has opened its inaugural clinic in Winter Park, Florida. This state-of-the-art facility offers groundbreaking treatments, including AHSCT for MS and various regenerative therapies utilizing stem cells and platelet-rich plasma (PRP). The clinic is designed to provide a nurturing and healing environment for those seeking advanced medical solutions.

Through its commitment to collaboration, advocacy, and quality care, ADIA aims to redefine the standard of treatment for MS patients, contributing to improved outcomes and quality of life for those affected by the disease. The company believes in transcending limitations to create a healthier and more vibrant future.